X-112779090-C-G
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_001113490.2(AMOT):āc.3064G>Cā(p.Val1022Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000222 in 1,198,916 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 88 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
NM_001113490.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AMOT | NM_001113490.2 | c.3064G>C | p.Val1022Leu | missense_variant | 13/14 | ENST00000371959.9 | NP_001106962.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AMOT | ENST00000371959.9 | c.3064G>C | p.Val1022Leu | missense_variant | 13/14 | 1 | NM_001113490.2 | ENSP00000361027.3 | ||
AMOT | ENST00000371962.5 | c.2368G>C | p.Val790Leu | missense_variant | 10/11 | 1 | ENSP00000361030.1 | |||
AMOT | ENST00000304758.5 | c.1837G>C | p.Val613Leu | missense_variant | 11/12 | 1 | ENSP00000305557.1 |
Frequencies
GnomAD3 genomes AF: 0.000107 AC: 12AN: 112227Hom.: 0 Cov.: 23 AF XY: 0.000175 AC XY: 6AN XY: 34375
GnomAD3 exomes AF: 0.0000826 AC: 15AN: 181508Hom.: 0 AF XY: 0.000119 AC XY: 8AN XY: 67334
GnomAD4 exome AF: 0.000234 AC: 254AN: 1086689Hom.: 0 Cov.: 29 AF XY: 0.000233 AC XY: 82AN XY: 352477
GnomAD4 genome AF: 0.000107 AC: 12AN: 112227Hom.: 0 Cov.: 23 AF XY: 0.000175 AC XY: 6AN XY: 34375
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | May 05, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at